文献速递临床试验与 GCP流行病学与生物统计

肺栓塞诊断策略对COPD急性加重住院患者临床结局的影响:随机临床试验

Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2021-01-01

本研究为西班牙18家医院开展的随机临床试验,纳入746例COPD急性加重住院患者,比较常规护理联合肺栓塞诊断策略与单纯常规护理。

要点

  • COPD急性加重住院患者加用肺栓塞诊断策略未显著改善90天复合结局。
  • 两组非致死性新发或复发性VTE、COPD再入院和全因死亡均无显著差异。
  • 大出血发生率组间无差异,该研究可能对复合结局各组分把握度不足。

核心结论

  • 在COPD急性加重住院患者中,常规护理联合肺栓塞诊断策略相比单纯常规护理未显著改善复合健康结局。

研究设计与样本

  • 多中心随机临床试验,在西班牙18家医院开展,纳入746例COPD急性加重住院患者,随机分为干预组(n=370)和对照组(n=367),最终737例完成试验。

主要发现

  • 非致死性新发或复发性VTE干预组0.5% vs 对照组2.5%,风险差-2.0%(95%CI -4.3%至0.1%)。
  • 90天内COPD再入院干预组25.4% vs 对照组22.9%,风险差2.5%(95%CI -3.9%至8.9%);全因死亡干预组6.2% vs 对照组7.9%,风险差-1.7%(95%CI -5.7%至2.3%)。

临床怎么用

  • 对于COPD急性加重住院患者,常规加用肺栓塞诊断策略未显示临床获益,临床决策需权衡个体风险。

局限性

  • 研究可能对复合结局的单个组分把握度不足。
  • 研究在西班牙18家医院开展,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Active search for pulmonary embolism (PE) may improve outcomes in patients hospitalized for exacerbations of chronic obstructive pulmonary disease (COPD). OBJECTIVE: To compare usual care plus an active strategy for diagnosing PE with usual care alone in patients hospitalized for COPD exacerbation. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial conducted across 18 hospitals in Spain. A total of 746 patients were randomized from September 2014 to July 2020 (final follow-up was November 2020). INTERVENTIONS: Usual care plus an active strategy for diagnosing PE (D-dimer testing and, if positive, computed tomography pulmonary angiogram) (n = 370) vs usual care (n = 367). MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of nonfatal symptomatic venous thromboembolism (VTE), readmission for COPD, or death within 90 days after randomization. There were 4 secondary outcomes, including nonfatal new or recurrent VTE, readmission for COPD, and death from any cause within 90 days. Adverse events were also collected. RESULTS: Among the 746 patients who were randomized, 737 (98.8%) completed the trial (mean age, 70 years; 195 [26%] women). The primary outcome occurred in 110 patients (29.7%) in the intervention group and 107 patients (29.2%) in the control group (absolute risk difference, 0.5% [95% CI, -6.2% to 7.3%]; relative risk, 1.02 [95% CI, 0.82-1.28]; P = .86). Nonfatal new or recurrent VTE was not significantly different in the 2 groups (0.5% vs 2.5%; risk difference, -2.0% [95% CI, -4.3% to 0.1%]). By day 90, a total of 94 patients (25.4%) in the intervention group and 84 (22.9%) in the control group had been readmitted for exacerbation of COPD (risk difference, 2.5% [95% CI, -3.9% to 8.9%]). Death from any cause occurred in 23 patients (6.2%) in the intervention group and 29 (7.9%) in the control group (risk difference, -1.7% [95% CI, -5.7% to 2.3%]). Major bleeding occurred in 3 patients (0.8%) in the intervention group and 3 patients (0.8%) in the control group (risk difference, 0% [95% CI, -1.9% to 1.8%]; P = .99). CONCLUSIONS AND RELEVANCE: Among patients hospitalized for an exacerbation of COPD, the addition of an active strategy for the diagnosis of PE to usual care, compared with usual care alone, did not significantly improve a composite health outcome. The study may not have had adequate power to assess individual components of the composite outcome. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02238639.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Jiménez D, Agustí A, Tabernero E, et al. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial. JAMA. 2021. PMID: 34609451. doi:10.1001/jama.2021.14846

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。